BioNTech Acquires Priority Review Voucher for $205 Million
BioNTech has purchased a $205 million FDA priority review voucher to accelerate drug approvals, while Johnson & Johnson is scaling back its commercial…

BioNTech has finalized the acquisition of a Priority Review Voucher (PRV) from Scholar Rock for a total consideration of $205 million. This transaction provides the purchaser with the right to an expedited six-month FDA review process for a future drug application, effectively shortening the standard regulatory timeline.
For the acquiring firm, the purchase represents a strategic investment in accelerating its clinical pipeline. The utilization of a PRV is a common mechanism for large-scale biotechnology firms to gain a competitive advantage in market entry, particularly for high-priority therapeutic candidates.
Priority Review Voucher
Simultaneously, Johnson & Johnson has initiated a strategic withdrawal of operations within the Norwegian market. This move reflects a broader trend of multinational pharmaceutical companies re-evaluating their geographic footprints to optimize operational costs and focus on core regional markets.
These developments highlight two distinct trends currently shaping the pharmaceutical sector: the aggressive pursuit of regulatory speed by well-capitalized firms and the ongoing consolidation of international commercial operations. Market participants should monitor how these shifts in regulatory strategy and regional presence impact the long-term valuation and operational efficiency of the involved entities.
More stories
- The Week in Games: GTA 6 turns attention into cash
- US data centres emit 25.7m tonnes of CO2, Harvard says
- German founders need 3,942 hours to open small business
- Leaked Deutsche Bank files test Sewing's reform narrative
- UAE employers plan 2.8% pay rises for 2027
- Bessent urges Nvidia to seek outside CEO as scrutiny grows
- CapitaLand, Neon target China's $2.8 trillion experience economy
- Listed firms in Indonesia face fire scrutiny as 2.88m hectares burned
- Hypercharge issues 18m shares to acquire REVS Charging, with a six-month lockup
- Scott Aerospace says Halifax unit will support Canadian naval bids and UK exports
Latest news
- Social Security raises 2027 benefits 3.6%
- Hull City 2–0 Brighton: When Resilience Beat Reputation
- David Parr House to honor Victorian art-workman with blue plaque
- Iran's attacks hit 25 tankers near Strait of Hormuz
- FCC approves prison cellphone jamming despite 2.5-mile warning
- Russia strikes Ukraine as Odesa faces electricity strain
- Bahrain reports two injuries after Iranian aerial attacks
- Congress tests Black Democrats' growing policy influence

